disulfiram has been researched along with Depressive Disorder, Major in 4 studies
Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although disulfiram and naltrexone have been approved by the Food and Drug Administration for the treatment of alcoholism, no medications have been approved for individuals with alcohol dependence and comorbid psychiatric disorders." | 5.12 | Naltrexone and disulfiram in patients with alcohol dependence and current depression. ( Carroll, K; Levinson, C; Nich, C; Petrakis, I; Poling, J; Ralevski, E; Rounsaville, B, 2007) |
| "Anxiety is common among persons with alcohol use disorder during early abstinence from alcohol." | 2.82 | Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study. ( Bhatt, S; Bogenschutz, MP; Bohan, J; Foster, B; Romo, P; Tonigan, JS; Wilcox, CE, 2016) |
| "2." | 1.51 | Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context. ( Beaglehole, B; Boden, JM; Foulds, J; Mulder, RT, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaglehole, B | 1 |
| Foulds, J | 1 |
| Mulder, RT | 1 |
| Boden, JM | 1 |
| Helton, SG | 1 |
| Lohoff, FW | 1 |
| Bogenschutz, MP | 1 |
| Bhatt, S | 1 |
| Bohan, J | 1 |
| Foster, B | 1 |
| Romo, P | 1 |
| Wilcox, CE | 1 |
| Tonigan, JS | 1 |
| Petrakis, I | 1 |
| Ralevski, E | 1 |
| Nich, C | 1 |
| Levinson, C | 1 |
| Carroll, K | 1 |
| Poling, J | 1 |
| Rounsaville, B | 1 |
1 review available for disulfiram and Depressive Disorder, Major
| Article | Year |
|---|---|
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety Disorders; Comorbidity; Depressi | 2015 |
2 trials available for disulfiram and Depressive Disorder, Major
| Article | Year |
|---|---|
Coadministration of disulfiram and lorazepam in the treatment of alcohol dependence and co-occurring anxiety disorder: an open-label pilot study.
Topics: Adult; Alcoholism; Anxiety Disorders; Craving; Depressive Disorder, Major; Disulfiram; Drug Therapy, | 2016 |
Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Topics: Alcohol Deterrents; Alcoholism; Bipolar Disorder; Cocaine-Related Disorders; Comorbidity; Connecticu | 2007 |
1 other study available for disulfiram and Depressive Disorder, Major
| Article | Year |
|---|---|
Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context.
Topics: Alcohol Deterrents; Alcoholism; Antidepressive Agents; Depressive Disorder, Major; Disulfiram; Femal | 2019 |